Bacteroidota: Mapping Your Gut's Fiber-Processing Phylum

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

The Bacteroidota test measures levels of Bacteroidota bacteria in your gut microbiome to detect imbalances associated with digestion, inflammation, and metabolic health. Identifying atypical Bacteroidota profiles can help guide dietary or lifestyle changes that may reduce risk of chronic gut issues and related metabolic problems.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Mapping your gut's fiber-processing phylum

The bacteroidota test analyzes DNA from your stool to estimate the relative abundance of microbes within the Bacteroidota phylum—organisms like Bacteroides, Prevotella, and Alistipes that specialize in breaking down complex carbohydrates and producing short-chain fatty acids. Modern sequencing approaches such as 16S rRNA profiling or whole-metagenome sequencing identify these microbes by their genetic signatures and compare your proportions to reference populations. Most results are reported as percentages rather than absolute counts, reflecting your current ecosystem balance rather than a permanent trait.

Why that matters: Bacteroidota help harvest energy from plant fibers, shape bile acid metabolism, produce compounds like acetate and propionate, and train the immune system at the gut lining. These activities influence digestion, inflammation, and metabolic signaling through the gut–brain and gut–liver axes. While microbiome science is evolving, consistent patterns emerge: stable diversity, adequate fiber-degrading capacity, and balanced representation of beneficial groups correlate with gut resilience. The bacteroidota test provides a focused window into that machinery.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

What this phylum signals about gut resilience

Real life example: imagine two breakfasts—steel-cut oats versus a sugar pastry. Bacteroidota-rich communities are built to digest the long-chain fibers in the oats, releasing short-chain fatty acids that help maintain the gut barrier and signal to muscle and liver about glucose use. When this group is markedly low or skewed, people may notice more gas with high-fiber foods, variable stools, or harder-to-predict post-meal energy. Testing helps identify dysbiosis patterns linked to symptoms, flags potential impacts from recent antibiotics or restrictive dieting, and clarifies how your current eating pattern is interacting with your microbes. It is especially useful after major diet shifts, persistent GI symptoms, or recent infections when you want to understand how your gut ecosystem is recovering.

Zooming out, the gut microbiome influences glucose regulation, lipid handling, inflammation, and even how your body feels during workout recovery by modulating immune signals. Longitudinal microbiome testing lets you see how adjustments—like increasing fermentable fibers or managing stress—are reflected in microbial diversity and function over time. The goal is not a “perfect” number but pattern recognition. You learn how your microbial community behaves, then collaborate with your care team to support digestion, energy, and long-term health—without chasing trends that outpace the evidence.

Interpreting your Bacteroidota percentage

Your report typically shows the percentage of Bacteroidota compared with other major phyla and may highlight key genera (for example, Bacteroides or Prevotella) against a reference range from healthy populations. In general, a balanced microbiome shows higher overall diversity and a reasonable presence of fiber-degrading bacteria. Dominance by a single group or unusually low representation can signal imbalance, but context is crucial: diet, geography, and culture all shape what “normal” looks like.

What “balanced” suggests: efficient breakdown of complex carbohydrates; robust short-chain fatty acid production (notably acetate and propionate) that supports gut barrier integrity; and a steadier inflammatory tone. People with balanced patterns often report more predictable digestion and less reactivity to fiber-rich foods, though individual responses vary widely.

What “dysbiotic” may indicate: reduced diversity; a loss of beneficial fiber-degraders; or a tilt toward species linked to inflammation. Because Bacteroidota are gram-negative, their cell-wall components can interact with immune pathways—yet many members provide net benefits by fermenting fibers and producing metabolites that calm inflammation. An out-of-range result is a flag for exploration rather than a diagnosis. It points to functional patterns that may respond to dietary fiber variety, stress reduction, and, if symptoms persist, medical evaluation.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Variables that shift the number without telling you much

Important limitations: stool testing captures what’s shed, not every microbe on the intestinal wall; results are relative proportions, which can shift with short-term diet changes or bowel habits; different labs and methods (16S vs. metagenomics) yield slightly different estimates; recent colonoscopy prep, antibiotics, or acute gastroenteritis can temporarily distort findings. That is why trends over time, plus your history and symptoms, tell the most useful story.

What to read alongside Bacteroidota

Big picture: microbiome data gain power when viewed alongside other biomarkers. Pairing bacteroidota test results with stool inflammation markers, metabolic labs, or even dietary logs can help your clinician triangulate the “why” behind your digestion and energy patterns. Think of this test as a map of your gut’s fiber-processing engine—valuable on its own, and even better when integrated into your broader health dashboard.

Frequently Asked Questions

References

  1. El Kaoutari A, Armougom F, Gordon JI, Raoult D, Henrissat B (2013). The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. *Nature Reviews Microbiology*, *11*(7), 497-504. https://doi.org/10.1038/nrmicro3050
  2. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. *Cell*, *165*(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
  3. Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. *Scientific Reports*, *11*, 3030. https://doi.org/10.1038/s41598-021-82726-y
  4. Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *The New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
  5. Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Gasbarrini A, Segata N, Cammarota G (2025). International consensus statement on microbiome testing in clinical practice. *The Lancet Gastroenterology & Hepatology*, *10*(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey